Copper Compound Clears 42% of Toxic Alzheimer’s Protein in Mouse Study
A drug already carrying years of human safety data from trials for Parkinson’s disease and ALS just produced a striking result in a different disease altogether. Researchers at Monash University gave the compound to mice bred to develop Alzheimer’s, then watched what happened inside the animals’ brains over eight weeks of treatment. Numbers from that …